1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQT
Arcutis Biotherapeutics, Inc.US flagNASDAQ Global Select
28.78
USD
+0.28
- -
3.60BMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
4
60
197
376
+ Sales & Services Revenue
- -
- -
- -
- -
- -
4
60
197
376
- Cost of Revenue
- -
- -
- -
- -
- -
1
5
19
37
+ Cost of Goods & Services
- -
- -
- -
- -
- -
1
5
19
37
Gross Profit
- -
- -
- -
- -
- -
3
55
177
339
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
4
20
43
137
207
305
296
306
352
+ Selling, General & Admin
1
2
7
21
61
122
185
229
275
+ Research & Development
3
18
37
115
146
182
111
76
77
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-4
-20
-43
-137
-207
-302
-241
-128
-12
- Non-Operating (Income) Loss
1
- -
-1
-1
- -
10
18
11
3
+ Interest Expense, Net
- -
- -
- -
- -
- -
16
17
11
3
+ Interest Expense
- -
- -
- -
- -
- -
16
30
27
12
- Interest Income
- -
- -
- -
- -
- -
- -
13
16
9
+ Other Non-Op (Income) Loss
1
- -
-1
-1
- -
-6
1
- -
- -
Pretax Income
-5
-19
-42
-136
-206
-311
-259
-139
-15
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
3
1
1
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-5
-19
-42
-136
-206
-311
-262
-140
-16
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-5
-19
-42
-136
-206
-311
-262
-140
-16
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-5
-19
-42
-136
-206
-311
-262
-140
-16
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-5
-19
-42
-136
-206
-311
-262
-140
-16
EBIT
-4
-20
-43
-137
-207
-302
-241
-128
-12
EBITDA
-4
-20
-43
-137
-206
-301
-240
-126
-8
EBITDA Margin (%)
- -
- -
- -
- -
- -
-8,157.7
-403.23
-64.33
-2.01
EBITA
-4
-20
-43
-137
-207
-302
-241
-128
-12
Gross Margin (%)
- -
- -
- -
- -
- -
79.54
91.63
90.27
90.24
Operating Margin (%)
- -
- -
- -
- -
- -
-8,183.04
-404.49
-65.33
-3.25
Profit Margin (%)
- -
- -
- -
- -
- -
-8,449.76
-439.79
-71.25
-4.29
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
1
1
2
5
Basic Weighted Avg Shares
18
18
35
36
49
55
69
121
127
Basic EPS, GAAP
-0.28
-1.07
-1.2
-3.8
-4.18
-5.66
-3.78
-1.16
-0.13
Basic EPS from Cont Ops
-0.28
-1.07
-1.2
-3.8
-4.18
-5.66
-3.78
-1.16
-0.13
Diluted Weighted Avg Shares
18
18
35
36
49
55
69
121
127
Diluted EPS, GAAP
-0.28
-1.07
-1.2
-3.8
-4.18
-5.66
-3.78
-1.16
-0.13
Diluted EPS from Cont Ops
-0.28
-1.07
-1.2
-3.8
-4.18
-5.66
-3.78
-1.16
-0.13

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
4
51
106
293
403
437
330
336
411
+ Cash, Cash Equivalents & STI
3
51
101
284
387
410
272
228
221
+ Cash & Cash Equivalents
3
39
63
65
96
54
88
71
43
+ ST Investments
- -
12
38
219
291
356
183
157
178
+ Accounts & Notes Receiv
- -
- -
- -
1
- -
8
26
73
146
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
8
26
73
146
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
1
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
8
13
15
23
+ Raw Materials
- -
- -
- -
- -
- -
6
10
4
5
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
1
5
+ Finished Goods
- -
- -
- -
- -
- -
1
3
10
13
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
5
8
16
12
20
20
21
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
1
5
5
12
11
13
22
+ Property, Plant & Equip, Net
- -
- -
- -
5
5
5
4
3
6
+ Property, Plant & Equip
- -
- -
1
5
6
6
6
6
9
- Accumulated Depreciation
- -
- -
- -
- -
1
1
2
3
3
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
7
7
10
16
+ Total Intangible Assets
- -
- -
- -
- -
- -
7
6
9
15
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
7
6
9
15
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
1
1
1
Total Assets
4
51
107
298
408
449
341
349
433
+ Payables & Accruals
1
2
4
18
24
23
31
60
108
+ Accounts Payable
1
2
1
7
7
9
12
14
13
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
11
16
14
19
46
96
+ ST Debt
- -
- -
- -
- -
- -
1
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
1
+ ST Finance Leases
- -
- -
- -
- -
- -
1
1
1
- -
+ Other ST Liabilities
- -
- -
1
4
9
14
15
20
21
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
1
4
9
14
15
20
21
Total Current Liabilities
1
3
5
23
33
38
47
81
130
+ LT Debt
- -
- -
- -
5
77
202
205
110
113
+ LT Borrowings
- -
- -
- -
- -
72
198
202
107
108
+ LT Finance Leases
- -
- -
- -
5
5
4
3
3
5
+ Other LT Liabilities
8
72
167
- -
- -
- -
1
1
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
8
72
167
- -
- -
- -
1
1
- -
Total Noncurrent Liabilities
8
72
167
5
77
202
206
110
114
Total Liabilities
9
75
172
28
110
240
253
191
243
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
1
473
706
930
1,071
1,279
1,328
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
1
473
706
930
1,071
1,279
1,328
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-5
-24
-66
-202
-408
-720
-982
-1,122
-1,138
+ Other Equity
- -
- -
- -
- -
- -
-1
- -
- -
- -
Equity Before Minority Interest
-5
-24
-65
271
298
210
89
158
189
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-5
-24
-65
271
298
210
89
158
189
Total Liabilities & Equity
4
51
107
298
408
449
341
349
433
Shares Outstanding
35
35
35
43
50
61
97
118
123
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
5
5
5
4
3
5
Net Debt
-3
-39
-63
-65
-24
144
113
36
66
Net Debt to Equity
68.46
164.23
97.4
-24.05
-8.1
68.77
127.9
22.77
34.86
Tangible Common Equity Ratio
-130.74
-46.94
-60.77
90.73
72.93
45.78
24.55
43.62
41.77
Current Ratio
5.52
19.12
20.33
12.96
12.09
11.57
7.08
4.15
3.17
Cash Conversion Cycle
- -
- -
- -
- -
- -
1,880.33
502.32
122.59
182.28

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-5
-19
-42
-136
-206
-311
-262
-140
-16
+ Depreciation & Amortization
- -
- -
- -
- -
- -
1
1
2
5
+ Non-Cash Items
1
3
1
8
28
63
38
41
41
+ Stock-Based Compensation
- -
- -
1
8
24
33
39
42
40
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
1
3
- -
- -
4
30
-1
-1
- -
+ Chg in Non-Cash Work Cap
- -
2
-2
14
4
-10
-24
-15
-35
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
-8
-17
-47
-73
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
-8
-6
- -
-7
+ (Inc) Dec in Prepaid Assets
- -
- -
-3
-3
-7
3
-9
-1
-2
+ Inc (Dec) in Accts Payable
1
2
2
18
11
3
9
34
48
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
-1
-1
-1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-14
-43
-113
-175
-258
-247
-112
-6
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
-1
-23
- -
-5
-11
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
-1
- -
- -
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
-23
- -
-5
-10
+ Cash (Repurchase) of Equity
- -
- -
- -
297
207
176
99
162
- -
+ Increase in Capital Stock
- -
- -
- -
297
207
176
99
162
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-12
-26
-182
-75
-64
181
34
-20
+ Dec in LT Investment
- -
- -
35
98
218
351
406
289
227
+ Inc in LT Investment
- -
-12
-61
-279
-293
-415
-226
-255
-247
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-12
-26
-182
-76
-87
180
29
-30
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
74
125
- -
-100
- -
+ Cash From Debt
- -
- -
- -
- -
74
125
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
-100
- -
+ Other Financing Activities
7
62
93
1
- -
1
2
5
7
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
7
62
93
298
282
302
101
66
7
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
3
36
24
3
31
-43
34
-17
-29
EBITDA
-4
-20
-43
-137
-206
-301
-240
-126
-8
EBITDA Margin (%)
- -
- -
- -
- -
- -
-8,157.7
-403.23
-64.33
-2.01
Free Cash Flow
-4
-14
-43
-113
-176
-281
-247
-117
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-14
-43
-113
-102
-133
-247
-212
-6
Free Cash Flow per Basic Share
-0.21
-0.78
-1.23
-3.18
-3.55
-5.11
-3.57
-0.97
-0.13
Price/Free Cash Flow
- -
- -
- -
-8.9
-5.9
-3.47
-0.91
-15.74
730.07
Cash Flow to Net Income
0.76
0.73
1.02
0.83
0.85
0.83
0.94
0.8
0.35
Capital Expenditures
- -
- -
- -
- -
-1
-23
- -
-5
-11